Cargando…

Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR(−/−) mouse model of atherosclerosis

Cardiovascular disease (CVD) is the most prevalent cause of mortality among patients with type 1 or type 2 diabetes, due to accelerated atherosclerosis. Recent evidence suggests a strong link between atherosclerosis and insulin resistance, due to impaired insulin receptor (IR) signalling. Here, we d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, Dawn, Morrice, Nicola, Grant, Louise, Le Sommer, Samantha, Lees, Emma K., Mody, Nimesh, Wilson, Heather M., Delibegovic, Mirela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365594/ https://www.ncbi.nlm.nih.gov/pubmed/28899902 http://dx.doi.org/10.1042/CS20171066

Ejemplares similares

Myeloid protein tyrosine phosphatase 1B (PTP1B) deficiency protects against atherosclerotic plaque formation in the ApoE(−/−) mouse model of atherosclerosis with alterations in IL10/AMPKα pathway
por: Thompson, D., et al.
Publicado: (2017)

Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR(−/−) mice
por: Thompson, Dawn, et al.
Publicado: (2023)

Response to comment by Moxon et al.
por: Thompson, Dawn, et al.
Publicado: (2018)

Direct comparison of methionine restriction with leucine restriction on the metabolic health of C57BL/6J mice
por: Lees, Emma K., et al.
Publicado: (2017)

Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism
por: Oliver, Helk, et al.
Publicado: (2023)

Adipocyte-Specific Protein Tyrosine Phosphatase 1B Deletion Increases Lipogenesis, Adipocyte Cell Size and Is a Minor Regulator of Glucose Homeostasis
por: Owen, Carl, et al.
Publicado: (2012)

Correction: Adipocyte-Specific Protein Tyrosine Phosphatase 1B Deletion Increases Lipogenesis, Adipocyte Cell Size and Is a Minor Regulator of Glucose Homeostasis
por: Owen, Carl, et al.
Publicado: (2012)

Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR(-/-) Mice on Western Type Diet
por: Kusters, Dennis H. M., et al.
Publicado: (2015)

Uptake of (68)gallium in atherosclerotic plaques in LDLR(-/-)ApoB(100/100 )mice
por: Silvola, Johanna MU, et al.
Publicado: (2011)

Serum levels of RBP4 and adipose tissue levels of PTP1B are increased in obese men resident in northeast Scotland without associated changes in ER stress response genes
por: Hoggard, Nigel, et al.
Publicado: (2012)

Deficiency of Adipocyte IKKβ Affects Atherosclerotic Plaque Vulnerability in Obese LDLR Deficient Mice
por: Lu, Weiwei, et al.
Publicado: (2019)

Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice
por: Morrice, Nicola, et al.
Publicado: (2017)

Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques
por: Searle, Amy K., et al.
Publicado: (2021)

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr (−/−) Mice Compared to Nondiabetic LDLr (−/−) Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2012)

Methionine restriction restores a younger metabolic phenotype in adult mice with alterations in fibroblast growth factor 21
por: Lees, Emma K, et al.
Publicado: (2014)

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice
por: Getz, Godfrey S., et al.
Publicado: (2018)

Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques
por: Van Vré, Emily A., et al.
Publicado: (2011)

A Proteomic Study of Atherosclerotic Plaques in Men with Coronary Atherosclerosis
por: Stakhneva, Ekaterina M., et al.
Publicado: (2019)

Atherosclerosis and Atheroma Plaque Rupture: Imaging Modalities in the Visualization of Vasa Vasorum and Atherosclerotic Plaques
por: Sun, Zhonghua
Publicado: (2014)

Autophagy in Atherosclerosis: A Phenomenon Found in Human Carotid Atherosclerotic Plaques
por: Liu, Huihui, et al.
Publicado: (2015)

Bacterial Communities Associated with Atherosclerotic Plaques from Russian Individuals with Atherosclerosis
por: Ziganshina, Elvira E., et al.
Publicado: (2016)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
por: Preusch, Michael R, et al.
Publicado: (2016)

Plasma Testosterone Levels and Atherosclerotic Plaque Gene Expression in Men With Advanced Atherosclerosis
por: Groepenhoff, Floor, et al.
Publicado: (2021)

The Search for Associations of Serum Proteins with the Presence of Unstable Atherosclerotic Plaque in Coronary Atherosclerosis
por: Stakhneva, Ekaterina Mikhailovna, et al.
Publicado: (2022)

Effects of Low Carbohydrate High Protein (LCHP) diet on atherosclerotic plaque phenotype in ApoE/LDLR(−/−) mice: FT-IR and Raman imaging
por: Wrobel, T. P., et al.
Publicado: (2015)

In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR(–/–)ApoB(100/100) mice
por: Blanco, Fabiana, et al.
Publicado: (2018)

Combined orcein and martius scarlet blue (OMSB) staining for qualitative and quantitative analyses of atherosclerotic plaques in brachiocephalic arteries in apoE/LDLR(−/−) mice
por: Gajda, Mariusz, et al.
Publicado: (2017)

Effects of Pharmacological Thermogenic Adipocyte Activation on Metabolism and Atherosclerotic Plaque Regression
por: Worthmann, Anna, et al.
Publicado: (2019)

An atherosclerotic plaque-targeted single-chain antibody for MR/NIR-II imaging of atherosclerosis and anti-atherosclerosis therapy
por: Zhang, Liwei, et al.
Publicado: (2021)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr(−/−) Mice
por: Peng, Xueying, et al.
Publicado: (2022)

Neutrophil-specific STAT4 deficiency attenuates atherosclerotic burden and improves plaque stability via reduction in neutrophil activation and recruitment into aortas of Ldlr(−/−) mice.
por: Keeter, W. Coles, et al.
Publicado: (2023)

Neutrophil-specific STAT4 deficiency attenuates atherosclerotic burden and improves plaque stability via reduction in neutrophil activation and recruitment into aortas of Ldlr(−/−) mice
por: Keeter, W. Coles, et al.
Publicado: (2023)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

Deletion of myeloid-PTP1B decreases MHC Class I expression and peptide presentation through an IL-10 dependent mechanism in response to LPS challenge
por: Le Sommer, Samantha, et al.
Publicado: (2015)

Fenretinide Treatment Prevents Diet-Induced Obesity in Association With Major Alterations in Retinoid Homeostatic Gene Expression in Adipose, Liver, and Hypothalamus
por: Mcilroy, George D., et al.
Publicado: (2013)

Deficiency of CCAAT/Enhancer Binding Protein-Epsilon Reduces Atherosclerotic Lesions in LDLR−/− Mice
por: Okamoto, Ryoko, et al.
Publicado: (2014)

Cardiotonic Pills Plus Recombinant Human Prourokinase Ameliorates Atherosclerotic Lesions in LDLR(–/–) Mice
por: Deng, Jing-Na, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3frjph1arcvs7hnsud9kmlb3fp